Qingdao Huaren Pharmaceutical imperial create a new model of marketing cooperation: "1 + X = 1" Charm

AD December 9, 2010, Nanchang.

    In the 64th National Drug Fair venue - Nanchang International Exhibition Center exhibition hall C, imperial Qingdao Huaren Pharmaceutical Co., Ltd. from Shandong Qingdao special fashion show special attention of visitors, who flocked to the Advisory . Attract them there are two points: First, the company presented a patented exclusive product - "Pu Yuan and stomach Capsule", the second is marketing new model of cooperation "1 + X = 1".

It is understood that this Yaojiao Hui reached more than 3,000 exhibitors, product information before piling up various booths, in order to win the eye in many competitors is not easy. But set to attend the exhibition of imperial Qingdao Huaren Pharmaceutical Co., Ltd. Deputy General Manager Xu Yuanhu told reporters that he did a bit rough in the morning and statistics, the average per minute to more than 20 people to discuss cooperation.

    Xu Yuanhu registration form while turning aside to reporters, said: "requires the cooperation of friends there, their concerns are mainly two aspects, one is the efficacy of the product itself, on the other hand is the cooperative mode Pu Yuan and Ming from stomach capsule. at the end of the Early Qing court Queen's party, is the only batch of nearly four years of Chinese stomach drugs, efficacy is not a problem this time we launched a special '1 + X = 1' innovative cooperation model, the model lifted partner in the traditional marketing model under all concerns. "

    Under the new health care reform in the new environment, the product will rely on to gain market vitality and bright future of it?

Quality is the market permits

Reporters learned that, last August that only the products listed, in fact, has a long history of efficacy and safety has withstood the test of time, it can be passed so far.

"Pu Yuan and stomach capsule" formerly called "stomach panacea", was originally a palace of Queen Square, the offering by private doctor Lee, because Emperor Kangxi cure gastritis obtained Ciming. The drug court by nobles of all ages and praise, twists and turns, the world survived, after becoming Affiliated Hospital of Qingdao University Medical preparations in the same species in prescription ranked first in 2006 by the imperial Huaren Pharmaceutical introduced and improved to "Pu yuan and stomach capsule."

Xuyuan Hu told the author, has been on Huaren Pharmaceutical imperial and Affiliated Hospital of Qingdao University Medical College, authoritative medical research institutions have extensive technical cooperation, and cooperation of national research and development of new drugs - Pu Yuan and stomach capsule, from Qingdao University Medical Affiliated hospital hospital dozen Ph.D., experts on the basis of the traditional recipe, after ten years of clinical research, through clinical observation of nearly a thousand patients, continuous improvement, the use of modern biotechnology successfully developed the latest stomach.

" 'Pu Yuan and stomach capsule' were characterized by the liver and stomach, gas pain, remove saprophytic new for the law, selection of natural medicine, according to the testimonies monarch strict prescriptions, has almost 80 years experience in clinical application." Xuyuan Hu said, "with respect to the evidence-based medicine in terms of modern medicine," Pu yuan and stomach capsule "has already experienced the history and evidence-based verification of a large sample, in line with the concept of the modern treatment of gastritis and peptic ulcer - stomach and balance , cure stomach this. "

Xuyuan Hu pointed out that a product in the market, there is no vitality, first of all depend on the nature of the product. And the product in 1995 as a research project of Qingdao University Medical College, officially approved for up to three years of preclinical research, including prescription prescription basis, the effectiveness of component analysis, all aspects of toxicology, pharmacodynamics and the like. According to modern medicine extraction and preparation of new technical requirements for the production process of trial and error conditions, we made a number of research results, to achieve a breakthrough formulation technology, the research results obtained in Shandong Province Science and Technology Progress Award. In 2006, the introduction of Huaren Century Group has completed clinical studies Pu Yuan and stomach capsule, and through the review of drugs and drug registration approval document certificate. In 2008, Pu Yuan and stomach capsule enterprise State Ministry of Science and Innovation Fund 1 million yuan two national patents.

"Data is the most convincing, in addition to numerous clinical case history verification, from 2003 to 2005, Pu Yuan and stomach capsule in clinical specifically for peptic ulcer were carried out in 480 cases of clinical research, Ⅲ Study Results display test group ulcer cure rate was 55.95%, Syndrome cure rate was 64.88%;. duodenal ulcer cure rate was 54.76%, Syndrome cure rate was 57.14% shows that the "Pu yuan and stomach capsule "as a basis for gastritis peptic ulcer medication, is experiencing the history of evidence-based verification and modern evidence-based medicine, quality assurance, quality is the market permits." Xuyuan Hu concluded.

Huge potential for stomach medicine

The birth of a brand product, requires a number of conditions, in addition to the excellent quality of the product itself, the decisive factor is whether or not marketable. Many products in the market stomach, when the birth of Pu Yuan and stomach capsules whether it should be?

Xu Yuanhu analysts believe that 20 years, stomach products market has become a relatively mature market, the formation of many brands, some brands already have several years or ten years of history. But in the eight initial marketing nineties of the last century, most of the stomach is the product by huge advertising investment and open markets. In recent years, increasingly sophisticated consumer psychology, the characteristics of the retail pharmaceutical market changes and so on, many marketing models are difficult to achieve the desired input-output ratio, which led to the OTC market competition including the stomach, including more and more intense.

At the same time, although more and more homogeneous product, increasingly fierce market competition, but the prospect of digestive drug market attractive. According to the data SFDA Southern Medicine Economic Research Institute, the proportion of domestic digestive drugs in sample hospitals in the country in recent years has remained at between 12% -13%. Domestic gastrointestinal drug market in 2009 more than 23 billion yuan (calculated according to the retail price), the next few years is expected to maintain its growth rate at around 10% -11%, the gastrointestinal drug has a broad market prospect.

Gastritis and peptic ulcer disease is one of the highest incidence in China, there are statistics show that about 80% of patients between the ages of 20-50 years, while about 10% of foreign person's life suffered from ulcer disease. Although the last two decades, modern medicine canker basic and clinical research has made great progress, especially cimetidine, ranitidine, famotidine and omeprazole acid proton pump inhibitors widely used, greatly improving the efficacy of the disease, but there are still many problems has not been fundamentally resolved, such as the recurrent problem of ulcer disease, the recurrence rate after six months to a year of treatment is about 30% -50 cimetidine %. In addition, clinical observations indicate the presence of these drugs are also more single action, such as lack of comprehensive efficacy is not ideal.

According to Xu Yuanhu introduction, because the stomach can not reach western modern medicine recognized the desired effect, so the number of domestic and foreign medical institutions of traditional Chinese medicine to try to overcome this difficult period. Clinical Study of Treatment of gastritis and peptic ulcer disease has been carried out for many years, and achieved certain results, but in recent years there are many drugs available, but due to the current medicine, drug development the existence of inherent limitations and one-sidedness, efficacy and not ideal. However, it only shows on gastritis and peptic ulcer treatment, clinical outcomes for reference medicine, can find new and effective drugs instead.

Xuyuan Hu said: "Pu Yuan and stomach medicine capsules belong to stomach, it is based on the characteristics of liver and stomach, gas pain, remove saprophytic new law as a rule, by adjusting qi, so that Wei Qi Ann, collapse Xiaotong only, this treatment method etiology, pathogenesis, disease locations, disease Hou are highly targeted, reflecting the principles of Chinese medicine syndrome differentiation, while both specimens, the overall combined with local, fully reflects the overall Chinese medicine treatment concept, "Pu yuan and stomach capsule" will be further confirmed in another study after extensive clinical market, in the stomach of a huge potential market highlight the unique charm of Chinese stomach of new drugs. "

"1 + X = 1" to the power of marketing

"Sell themselves" good product and then a big market potential, if not a good brand marketing model is also difficult, at the imperial Qingdao Huaren Pharmaceutical, Pu Yuan and stomach capsule innovative marketing has been included in the heavy work heavy, and have a clear strategic plan and objectives - Pu yuan and stomach capsule marketing adopted a "three-step" strategy to open up that market to create the basis for the first year, second year, a national incubator, the third class of drugs became digestion major brands. Five years, a single product turnover Pu Yuan and stomach capsule will be more than 300 million yuan.

Currently, Wah Yan imperial doctor medicine has formed over hundreds of professional marketing team, focusing on the establishment of a sound national marketing network, to expand the market. Xuyuan Hu told reporters, Wah Yan imperial medicine in the 64th Yaojiao Hui set exhibition, not only for the industry to offer "Pu Yuan and stomach capsule" This exclusive patented products, but also hope to expand the current marketing environment specifically Release of "1 + X = 1" marketing model, win-win cooperation with friends around the country.

Xuyuan Hu explained that the so-called "1 + X = 1" mode, the first "1" refers to Qingdao Huaren imperial medicine platform, while "X" is N partners, "also said is, whether you are only resource or a friend to a hospital in the provincial hospital resources, can become partners imperial Qingdao Huaren Pharmaceutical, Qingdao Huaren Pharmaceutical imperial will be considered part of their company, followed by "1" refers to the efforts of both sides, unity thinking, unity of purpose, unity of action to achieve win-win situation in Qingdao Huaren imperial platform as a whole. "

Many consultants have to Xuyuan Hu raised the same problem, as Chinese medicine stomach new drug capsule Pu Yuan and stomach, whether the market really optimistic about the prospects? Xuyuan Hu replied, stomach Chinese market has great potential, this is no doubt, "Pu Yuan and stomach capsule" has experienced a history of modern evidence-based medicine and evidence-based verification, quality guaranteed efficacy, but also in line with accepted modern medical treatment concept stomach - - overall balance aggressive factors and defensive factors. "Further more the result of the drug from the listed just one year, the current has entered the country more than 10 provinces and cities, more than 300 hospitals, market prospects for the future.

I believe in the imperial Qingdao Huaren Pharmaceutical Innovation "1 + X = 1" marketing model, driven by the joint efforts of N multiple partners classical tradition innovation, "Pu Yuan and stomach Capsule" will benefit the whole people per class a stomach - stomach balance, gastric motility, gastric health, for the world.